Document is current
Any future updates will be listed below
-
Authors
Rautenberg, Christina https://orcid.org/0000-0002-0611-1372
Pyka, Jacob
Lohmann, Tim https://orcid.org/0000-0002-3216-0784
Kaivers, Jennifer
Mohring, Annemarie
Schneider, Artur
Leimkühler, Nils
Reinhardt, H. Christian
Metzdorf, Judith
Schroeder, Thomas
- License Information
-
More Information
Article History
Received: 23 June 2025
Revised: 19 July 2025
Accepted: 27 August 2025
First Online: 9 September 2025
Competing interests
: TS: Advisory Board with honoraria: JAZZ Pharmaceuticals, AbbVie; lecture fees: JAZZ Pharmaceuticals, Medac, AbbVie; Research Funding: JAZZ Pharmaceuticals; BMS/Celgene Deutschland GmbH; Financial travel support: JAZZ Pharmaceuticals, BMS/Celgene Deutschland GmbH, Medac, AbbVie. Christina Rautenberg: Advisory Board with honoraria: BMS/Celgene Deutschland GmbH, Servier; Lecture fees: JAZZ Pharmaceuticals, BMS/Celgene Deutschland GmbH, Pfizer; Financial travel support: JAZZ Pharmaceuticals, BMS/Celgene Deutschland GmbH, medac, AbbVie; Research Funding: JAZZ Pharmaceuticals.
: All methods were performed in accordance with the relevant guidelines and regulations. The study was approved by the ethics committee of the University Hospital Essen (approval number: 22-10708-BO).
